Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 7/20 | 0.64 |
| ▸ | AOC2 | O75106 | 11/20 | 0.57 |
| ▸ | CA12 | O43570 | 5/20 | 0.47 |
| ▸ | CA1 | P00915 | 5/20 | 0.47 |
| ▸ | CA2 | P00918 | 5/20 | 0.47 |
| ▸ | CA9 | Q16790 | 5/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24906961 | 0.94 | AOC2 (0.67) | MAOBAOC2CA12CA1CA2 | |
| SCHEMBL23370068 | 0.88 | AOC2 (0.66) | MAOBAOC2CA12CA1CA2 | |
| SCHEMBL24295299 | 0.87 | CA1 (0.63) | MAOBAOC2CA12CA1CA2 | |
| SCHEMBL23852233 | 0.87 | CA1 (0.63) | MAOBAOC2CA12CA1CA2 | |
| SCHEMBL16767547 | 0.85 | CA12 (0.47) | MAOBAOC2CA12CA1CA2 | |
| SCHEMBL16767549 | 0.85 | CA12 (0.47) | MAOBAOC2CA12CA1CA2 | |
| SCHEMBL23369999 | 0.84 | MAOA (0.67) | MAOBAOC2MAOA | |
| SCHEMBL23370207 | 0.83 | AOC2 (0.64) | MAOBAOC2MAOA | |
| SCHEMBL23370199 | 0.83 | AOC2 (0.44) | MAOBAOC2CA12CA1CA2 | |
| SCHEMBL23329639 | 0.83 | MAOB (0.46) | MAOBAOC2CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230026801-A1 | SSAO INHIBITORS AND USE THEREOF | ECCOGENE INC. | 2023-01-26 | — | — | US | disclosed |
| US-20210147360-A1 | SSAO INHIBITORS AND USE THEREOF | ECCOGENE INC. | 2021-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230026801-A1 | SSAO INHIBITORS AND USE THEREOF | SSB, HAO1, SORD | MAOB 21/4885AOC2 39/4885CA12 2332/4885 |
| US-20210147360-A1 | SSAO INHIBITORS AND USE THEREOF | SSB, HAO1, SORD | MAOB 21/4885AOC2 39/4885CA12 2332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.